Whole genome sequencing data of paediatric T cell acute lymphoblastic leukemia (T-ALL)
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy accounting for approximately 15–25% of pediatric and adult ALL cases. Despite significant therapeutic improvements over the last decade, the prognosis of T-ALL remains less favorable than that of B-ALL, with 5-year EFS and OS of around 76–82% and 80–88%, respectively, depending on the treatment protocol used. T-ALL patients often suffer from failure of induction therapy or early relapse, which is associated with a dismal prognosis. Approximately 10–15% of T-ALL patients experience relapse, and survival after relapse is poor.
- Type: Whole Genome Sequencing
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000002013 | Illumina HiSeq X | 2 | |
| EGAD50000002014 | Illumina HiSeq X Illumina NovaSeq 6000 | 5 | |
| EGAD50000002015 | Illumina NovaSeq 6000 Illumina NovaSeq X Plus | 5 |
